Uncovering the mechanism of Qidan Dihuang Granule in the treatment of diabetic kidney disease combined network pharmacology, UHPLC-MS/MS with experimental validation
Background and aim: Diabetic Kidney Disease (DKD) is a common microvascular complication of diabetes mellitus. Multi-center, randomized controlled trials have shown that Qidan Dihuang Granule (QDDHG) reduces the levels of albuminuria of DKD. However, the specific mechanisms of QDDHG on DKD are not c...
Main Authors: | Lei Xiang, Xiangsheng Cai, Xiaoshan Zhao, Yuanling Liu, Ya Xiao, Pingping Jiang, Lianghong Yin, Dan Song, Xuefeng Jiang |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Elsevier
2023-11-01
|
丛编: | Heliyon |
主题: | |
在线阅读: | http://www.sciencedirect.com/science/article/pii/S2405844023089223 |
相似书籍
-
Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson’s Disease by Suppressing the JNK/AP-1 Pathway
由: Li Wang, et al.
出版: (2021-04-01) -
Corrigendum: Compound Dihuang Granule inhibits nigrostriatal pathway apoptosis in Parkinson’s disease by suppressing the JNK/AP-1 pathway
由: Li Wang, et al.
出版: (2023-12-01) -
Deciphering the Mechanism of Xijiao Dihuang Decoction in Treating Psoriasis by Network Pharmacology and Experimental Validation
由: Guo Y, et al.
出版: (2023-09-01) -
Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Liuwei Dihuang Decoction Against Intervertebral Disc Degeneration
由: Zhang H, et al.
出版: (2021-12-01) -
Integrated network pharmacology and transcriptomics to explore the mechanism of compound Dihuang granule (CDG) protects dopaminergic neurons by regulating the Nrf2/HMOX1 pathway in the 6-OHDA/MPP+-induced model of Parkinson’s disease
由: Xue Sun, et al.
出版: (2024-12-01)